HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of U74500A on phorbol myristate acetate-induced acute lung injury.

Abstract
1. The present study was designed to determine whether U74500A could ameliorate acute lung injury (ALI) induced by phorbol myristate acetate (PMA) in our rat isolated lung model compared with any amelioration induced by dimethylthiourea (DMTU), superoxide dismutase (SOD) and catalase. 2. Acute lung injury was induced successfully by PMA during 60 min of observation. At 2 microg/kg, PMA elicited a significant increase in microvascular permeability (measured using the capillary filtration coefficient Kfc), lung weight gain, the lung weight/bodyweight ratio, pulmonary arterial pressure and protein concentration of the bronchoalveolar lavage fluid. 3. Pretreatment with 1.5 mg/kg U74500A significantly attenuated ALI; there was no significant increase in any parameters measured, except for pulmonary arterial pressure. The protective effect of U74500A was approximately the same as that of 600 mg/kg DMTU. However, 6000 U/kg SOD, 50,000 U/kg catalase and 6000 U/kg SOD + 50,000 U/kg catalase had no protective effect. 4. These experimental data suggest that U74500A significantly ameliorates ALI induced by PMA in rats.
AuthorsShi-Jye Chu, Deh-Ming Chang, David Wang, Hen-I Lin, Shih-Hua Lin, Kang Hsu
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) Vol. 31 Issue 8 Pg. 523-9 (Aug 2004) ISSN: 0305-1870 [Print] Australia
PMID15298545 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pregnatrienes
  • U 74500A
  • Tetradecanoylphorbol Acetate
Topics
  • Animals
  • Bronchoalveolar Lavage Fluid (cytology)
  • Male
  • Pregnatrienes (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Respiratory Distress Syndrome (chemically induced, pathology, prevention & control)
  • Tetradecanoylphorbol Acetate (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: